Soleno Therapeutics Inc (SLNO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 20,890 | -22,468 | -48,481 | -43,773 | -175,850 |
| Depreciation Amortization | 2,052 | 1,534 | 1,023 | 504 | 1,987 |
| Accounts receivable | -28,208 | -25,506 | -24,624 | N/A | N/A |
| Accounts payable and accrued liabilities | 3,612 | -674 | -2,603 | -3,336 | 5,672 |
| Other Working Capital | -24,633 | -18,218 | -24,773 | -6,356 | 6,018 |
| Other Operating Activity | 73,085 | 63,426 | 54,098 | 20,209 | 93,077 |
| Operating Cash Flow | $46,798 | $-1,906 | $-45,360 | $-32,752 | $-69,096 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -73 | -15 | -14 | -5 | -218 |
| Purchase Of Investment | -455,776 | -267,936 | -104,764 | -45,358 | -356,464 |
| Sale Of Investment | 254,068 | 191,530 | 119,800 | 68,300 | 131,000 |
| Investing Cash Flow | $-201,781 | $-76,421 | $15,022 | $22,937 | $-225,682 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 238,110 | 237,156 | 19,180 | 3,280 | 213,025 |
| Common Stock Repurchased | -100,146 | N/A | N/A | N/A | N/A |
| Other Financing Activity | -803 | -95 | -273 | -62 | 0 |
| Financing Cash Flow | $137,161 | $237,061 | $18,907 | $3,218 | $213,025 |
| Beginning Cash Position | 87,928 | 87,928 | 87,928 | 87,928 | 169,681 |
| End Cash Position | 70,106 | 246,662 | 76,497 | 81,331 | 87,928 |
| Net Cash Flow | $-17,822 | $158,734 | $-11,431 | $-6,597 | $-81,753 |
| Free Cash Flow | |||||
| Operating Cash Flow | 46,798 | -1,906 | -45,360 | -32,752 | -69,096 |
| Capital Expenditure | -73 | -15 | -14 | -5 | -218 |
| Free Cash Flow | 46,725 | -1,921 | -45,374 | -32,757 | -69,314 |